N,N-bis(1H-benzimidazol-2-ylmethyl)-N-benzylamine chromium (III) chloride → N,N-bis(1H-benzimidazol-2-ylmethyl)-N-benzylamine chromium (III) chloride hexafluoroantimonate tetrahydrofuran

HRID 1645213Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1645213
[O:1]1[CH2:5][CH2:4][CH2:3][CH2:2]1.[F:6][Sb-:7]([F:12])([F:11])([F:10])([F:9])[F:8].[Cl-:13].[Cr+3:14].N1C2C=CC=CC=2N=C1CNCC1NC2C=CC=CC=2N=1.[Cl-].[Cr+3].[NH:38]1[C:42]2[CH:43]=[CH:44][CH:45]=[CH:46][C:41]=2[N:40]=[C:39]1[CH2:47][N:48]([CH2:56][C:57]1[NH:61][C:60]2[CH:62]=[CH:63][CH:64]=[CH:65][C:59]=2[N:58]=1)[CH2:49][C:50]1[CH:55]=[CH:54][CH:53]=[CH:52][CH:51]=1.[Cl-].[Cl-]>F[Sb-](F)(F)(F)(F)F.[Ag+]>[O:1]1[CH2:5][CH2:4][CH2:3][CH2:2]1.[F:6][Sb-:7]([F:12])([F:11])([F:10])([F:9])[F:8].[Cl-:13].[Cr+3:14].[NH:38]1[C:42]2[CH:43]=[CH:44][CH:45]=[CH:46][C:41]=2[N:40]=[C:39]1[CH2:47][N:48]([CH2:56][C:57]1[NH:58][C:59]2[CH:65]=[CH:64][CH:63]=[CH:62][C:60]=2[N:61]=1)[CH2:49][C:50]1[CH:55]=[CH:54][CH:53]=[CH:52][CH:51]=1

Komponenten

4

Edukt 2

HCID 86638462N,N-bis(1H-benzimidazol-2-ylmethyl)-N-benzylamine chromium (III) chlorideHCID 86638469N,N-bis(1H-benzimidazol-2-ylmethyl)amine chromium (III) chloride hexafluoroantimonate tetrahydrofuran

Produkt 1

HCID 86638470N,N-bis(1H-benzimidazol-2-ylmethyl)-N-benzylamine chromium (III) chloride hexafluoroantimonate tetrahydrofuran

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 16687962Silver hexafluoroantimonateKatalysator

Versuchsvorschrift

4d was synthesised by an analogous procedure to that described for 4a using silver hexafluoroantimonate (0.20 g, 0.57 mmol) and complex 3d (0.30 g, 0.57 mmol). Yield 0.31 g, 68%. +FAB-MS: (m/e): 489 ([M]+), 454 ([M-Cl]+). −FAB-MS: (m/z): 235 ([M]−).

Quellen und Nachweise

ORD-Eintrag
ord-a1b2b7bf60704172a50648da50812bc5
Quelldatensatz
uspto-grants-2012_02
Patentnummer
US08124698B2

Notizen zur Reaktion

Wird geladen…